Analysen zu Novo Nordisk
| 07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.08.24 | Novo Nordisk Neutral | UBS AG | |
| 31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 19.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 12.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.07.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 02.07.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.06.24 | Novo Nordisk Neutral | UBS AG | |
| 27.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 25.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 14.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 30.05.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 15.05.24 | Novo Nordisk Neutral | UBS AG | |
| 14.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 14.05.24 | Novo Nordisk Neutral | UBS AG | |
| 08.05.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.05.24 | Novo Nordisk Overweight | Barclays Capital | |
| 06.05.24 | Novo Nordisk Neutral | UBS AG | |
| 03.05.24 | Novo Nordisk Halten | DZ BANK | |
| 03.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | Novo Nordisk Overweight | Barclays Capital | |
| 02.05.24 | Novo Nordisk Neutral | UBS AG | |
| 02.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 13.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.09.23 | Novo Nordisk Overweight | Barclays Capital | |
| 07.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.09.23 | Novo Nordisk Sell | UBS AG | |
| 05.09.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.09.23 | Novo Nordisk Overweight | Barclays Capital | |
| 30.08.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 15.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.08.23 | Novo Nordisk Overweight | Barclays Capital |
Aktuelle Aktienanalysen
| 03.12.24 | Prosus Buy | Deutsche Bank AG | |
| 03.12.24 | SÜSS MicroTec Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.12.24 | ATOSS Software Buy | Deutsche Bank AG | |
| 03.12.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Enel Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | BMW Buy | Deutsche Bank AG | |
| 03.12.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Sanofi Sell | Deutsche Bank AG | |
| 03.12.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | FedEx Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Siemens Healthineers Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Philips Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Stellantis Equal Weight | Barclays Capital | |
| 03.12.24 | HUGO BOSS Buy | UBS AG | |
| 03.12.24 | Volkswagen Overweight | Barclays Capital | |
| 03.12.24 | Valeo Equal Weight | Barclays Capital | |
| 03.12.24 | Michelin Underweight | Barclays Capital | |
| 03.12.24 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Continental Overweight | Barclays Capital | |
| 03.12.24 | Porsche Automobil vz. Underweight | Barclays Capital | |
| 03.12.24 | AIXTRON Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.12.24 | Mercedes-Benz Group Underweight | Barclays Capital | |
| 03.12.24 | Porsche Overweight | Barclays Capital | |
| 03.12.24 | BMW Equal Weight | Barclays Capital | |
| 03.12.24 | KION GROUP Buy | UBS AG | |
| 03.12.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Valeo Neutral | UBS AG | |
| 03.12.24 | easyJet Buy | UBS AG | |
| 03.12.24 | EssilorLuxottica Neutral | UBS AG | |
| 03.12.24 | Volkswagen Sell | UBS AG | |
| 03.12.24 | Mercedes-Benz Group Neutral | UBS AG | |
| 03.12.24 | Porsche Neutral | UBS AG | |
| 03.12.24 | BMW Buy | UBS AG | |
| 02.12.24 | Schneider Electric Overweight | JP Morgan Chase & Co. | |
| 02.12.24 | Hennes & Mauritz AB Buy | UBS AG | |
| 02.12.24 | BMW Equal Weight | Barclays Capital | |
| 02.12.24 | Porsche Overweight | Barclays Capital | |
| 02.12.24 | BASF Buy | Baader Bank | |
| 02.12.24 | JENOPTIK Halten | DZ BANK | |
| 02.12.24 | Merck Kaufen | DZ BANK | |
| 02.12.24 | Siemens Healthineers Neutral | UBS AG | |
| 02.12.24 | Novo Nordisk Neutral | UBS AG | |
| 02.12.24 | K+S Neutral | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.